Quick Answer
InfuSystem Holdings, Inc reported Cash and Equivalents of $3.19 million for fiscal year 2025.
InfuSystem Holdings, Inc Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $3.19M | +504.6% |
| 2024 | $527.0K | +128.1% |
| 2023 | $231.0K | +40.0% |
| 2022 | $165.0K | -11.3% |
| 2021 | $186.0K | -98.1% |
| 2020 | $9.65M | +264.5% |
| 2019 | $2.65M | -38.7% |
| 2018 | $4.32M | +24.5% |
| 2017 | $3.47M | +2.1% |
| 2016 | $3.40M | +315.4% |
| 2015 | $818.0K | +58.8% |
| 2014 | $515.0K | -54.7% |
| 2013 | $1.14M | -51.1% |
| 2012 | $2.33M | +191.1% |
| 2011 | $799.0K | -84.1% |
| 2010 | $5.01M | -35.3% |
| 2009 | $7.75M | -32.7% |
| 2008 | $11.51M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $955.0K | +151.3% | +32.6% |
| June 30, 2025 | $720.0K | +393.2% | -52.2% |
| March 31, 2025 | $1.51M | +83.2% | +185.8% |
| December 31, 2024 | $527.0K | +128.1% | +38.7% |
| September 30, 2024 | $380.0K | +136.0% | +160.3% |
| June 30, 2024 | $146.0K | +9.0% | -82.2% |
| March 31, 2024 | $822.0K | +221.1% | +255.8% |
| December 31, 2023 | $231.0K | +40.0% | +43.5% |
- InfuSystem Holdings, Inc showed an increase of +504.6% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2008–2025 period, InfuSystem Holdings, Inc’s cash and equivalents has declined by 72.3% (from $11.51 million to $3.19 million).
- The most recent figure is from InfuSystem Holdings, Inc’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: